Table 4.
Evaluation of Each Didactic
| Didactic | Overall satisfaction (SD) | Effective tools (SD) | Learned (SD) | Scope (SD) | Will apply (SD) | Training goals met (%) |
|---|---|---|---|---|---|---|
| Transgender 101 | 4.46 (0.60) | 4.33 (0.51) | 4.12 (0.73) | 4.34 (0.61) | 4.40 (0.63) | 93 |
| Enhancing provider and patient communication | 4.22 (0.63) | 4.26 (0.61) | 4.07 (0.86) | 4.11 (0.86) | 4.30 (0.71) | 71 |
| Mental health evaluation for hormone therapy | 4.38 (0.61) | 4.25 (0.87) | 4.31 (0.79) | 4.41 (0.62) | 4.38 (0.61) | 92 |
| Transitioning | 4.38 (0.71) | 4.42 (0.59) | 4.38 (0.58) | 4.43 (0.66) | 4.43 (0.66) | 86 |
| Medical aspects of transgender care | 4.44 (0.50) | 4.30 (0.60) | 4.44 (0.50) | 4.44 (0.50) | 4.22 (0.60) | 87 |
| Being a good consultant | 4.36 (0.64) | 4.30 (0.64) | 4.27 (0.62) | 4.32 (0.62) | 4.27 (0.62) | 91 |
| Medical assessment for feminizing hormones | 4.29 (0.63) | 4.30 (0.64) | 4.19 (0.85) | 4.20 (0.81) | 4.19 (0.59) | 80 |
| Prescribing feminizing hormones | 4.25 (0.66) | 4.31 (0.61) | 4.19 (0.63) | 4.25 (0.66) | 4.19 (0.63) | 81 |
| Medical assessment for masculinizing hormones | 3.94 (0.66) | 3.93 (0.59) | 4.13 (0.70) | 3.88 (0.70) | 3.88 (0.68) | 80 |
| Prescribing masculinizing hormones | 3.90 (0.30) | 4.13 (0.33) | 3.90 (0.54) | 4.00 (0.45) | 4.00 (0.63) | 79 |
| Writing support letters for transgender veterans | 4.31 (0.72) | 4.45 (0.66) | 4.15 (0.66) | 4.15 (0.66) | 4.31 (0.61) | 87 |
| Varieties of masculinizing surgeries | 4.18 (0.72) | 4.33 (0.67) | 4.36 (0.64) | 4.18 (0.72) | 3.91 (0.51) | 77 |
| Varieties of feminizing surgeries | 4.44 (0.68) | 4.75 (0.43) | 4.44 (0.68) | 4.33 (0.67) | 4.22 (0.63) | 80 |
| Introduction to DSD | 4.41 (0.60) | 4.21 (0.41) | 4.29 (0.57) | 4.12 (0.47) | 3.88 (0.32) | 81 |
0=not applicable; 1=strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree.